[News]LEESOL Secures 3 Billion KRW Series A2 Bridge Investment
11 Jun 2026
Mental healthcare tech company LEESOL announced on the 19th that it has successfully completed its Series A2 Bridge round of investment, totaling 3 billion KRW.
BNK Venture Capital led this round as the lead investor, with Spacetime Investment, Soo Investment Capital, and existing investor Vine Ventures joining as follow-on investors. Following the success of its 4 billion KRW Series A round in 2024, this bridge round brings LEESOL's total cumulative investment to over approximately 7.6 billion KRW. BNK Venture Capital, the lead investor, highly evaluated LEESOL—a designated "Baby Unicorn" company of Busan—for its technological prowess and growth potential driven by regional infrastructure.
Mental healthcare tech company LEESOL announced on the 19th that it has successfully completed its Series A2 Bridge round of investment, totaling 3 billion KRW.
BNK Venture Capital led this round as the lead investor, with Spacetime Investment, Soo Investment Capital, and existing investor Vine Ventures joining as follow-on investors. Following the success of its 4 billion KRW Series A round in 2024, this bridge round brings LEESOL's total cumulative investment to over approximately 7.6 billion KRW. BNK Venture Capital, the lead investor, highly evaluated LEESOL—a designated "Baby Unicorn" company of Busan—for its technological prowess and growth potential driven by regional infrastructure.
Go to News